Review Environments

Goal

Find correctness risks and regressions first, then assess maintainability and ecosystem compliance.

Review Input Modes

1. •Local environment module in ./environments/<env_name>.
2. •Pulled Hub environment via prime env pull owner/name.
3. •Installed package under active workspace.

Review Workflow

1. •Identify environment contract:

• •load_environment(...)
• •base class and rollout behavior
• •rubric and metrics

1. •Verify installability and runtime entrypoint:

prime env install <env>
prime eval run <env> -m gpt-4.1-mini -n 5

1. •Trace reward pipeline and validate scoring semantics.
2. •Run targeted checks for tool/stateful behavior where applicable.

Endpoint And Model Selection Nudge

1. •Encourage endpoint alias setup in configs/endpoints.toml for reproducible review runs.
2. •Ask whether review coverage should prioritize instruct or reasoning behavior.
3. •Instruct go-tos: gpt-4.1 series, qwen3 instruct series.
4. •Reasoning go-tos: gpt-5 series, qwen3 thinking series, glm series.

Critical Review Criteria

1. •Reward correctness:

• •Prefer deterministic, explicit checks or LLM judges.
• •Flag best-effort keyword or style heuristics unless explicitly approved.

1. •Environment self-containment:

• •Flag any requirement for user-managed background services before load_environment().
• •Require environment-managed lifecycle for sandboxes/sessions.

1. •Migration fidelity:

• •For ports, verify one-to-one equivalence of prompts, tool traces, and scoring logic.
• •Flag any assumptions made without user decision.

1. •Secrets handling:

• •Ensure required keys are validated in load_environment() with vf.ensure_keys(...).

1. •Performance and scaling:

• •Identify obvious bottlenecks in dataset loading, rubric calls, or tool execution.

Findings Format

Return findings first, sorted by severity:

1. •P0/P1 bugs and behavioral mismatches.
2. •P2 quality risks and maintainability issues.
3. •Test gaps and missing eval coverage. Include file paths, exact lines, impact, and concrete fix direction.

If No Findings

State explicitly that no defects were found, then list residual risk and untested areas.